Covid-19 vaccine Covaxin approval: WHO seeks more data from Bharat Biotech for Emergency Use Licensing

The EUL process is done by WHO and the Technical Advisory Group of independent experts who determine if the vaccine is quality-assured, safe and effective. The World Health Organisation’s (WHO)…

Continue ReadingCovid-19 vaccine Covaxin approval: WHO seeks more data from Bharat Biotech for Emergency Use Licensing

Coronavirus India Latest Update Live: India reports 30,948 new Covid-19 cases, 403 deaths in last 24 hours; Active cases lowest in 152 days

India has been reporting around 30,000 new Covid-19 cases for the past few weeksCoronavirus Case and Fatality Rate in India, Coronavirus Third Wave Today August 22 Live Updates: The fear…

Continue ReadingCoronavirus India Latest Update Live: India reports 30,948 new Covid-19 cases, 403 deaths in last 24 hours; Active cases lowest in 152 days

Coronavirus India Latest Update Live: India reports 36,571 new Covid-19 cases, 540 deaths; Active cases drop to 363,605, lowest in 150 days

The active caseload in the country dropped further to 3,63,605, the lowest in 150 days. (Picture: Reuters)Coronavirus Case and Fatality Rate in India, Coronavirus Third Wave Live Updates: India witnessed…

Continue ReadingCoronavirus India Latest Update Live: India reports 36,571 new Covid-19 cases, 540 deaths; Active cases drop to 363,605, lowest in 150 days

First day of FE Healthcare Summit began with deliberations on digital health, vaccine accessibility

Healthcare has today become more accessible and affordable with the use of modern technological interventions like artificial intelligence (AI), nano-technology, data analyticsThe first day of FE Healthcare Summit which began…

Continue ReadingFirst day of FE Healthcare Summit began with deliberations on digital health, vaccine accessibility

FE Healthcare Summit: Covaxin is outcome of complex science to achieve best efficacy, says Dr. Krishna Ella

Bharat Biotech has submitted its safety data to the Drugs Controller General of India (DCGI) based on the phase 2/3 clinical trials for manufacturing vaccine for children aged between 2…

Continue ReadingFE Healthcare Summit: Covaxin is outcome of complex science to achieve best efficacy, says Dr. Krishna Ella